DENIS CHEM LAB LTD
Latest filings
Next results: Wed, 4 Nov · Financial Results- Board to approve September quarter unaudited results · Results
- Foreign holder VS Holding B V cuts Denis Chem Lab stake by 2.05 percent · Ownership Changes
- Routine RTA compliance certificate for quarter ended September 2026 · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
Makes parenteral products, which are injectable pharmaceuticals. FY26 revenue was Rs. 181.72 crore with net profit of Rs. 8.41 crore on total assets of Rs. 124.83 crore. Materials account for 48.2% of revenue, with employee costs at 9.4%, other operating expenses at 27.1%, depreciation at 3.8% and annual capex at 2.6%. EBITDA margin stood at 10.77% in FY26. Operating cash flow dropped to Rs. 413 lakh from Rs. 1,209 lakh in FY25, while trade receivables grew by Rs. 804 lakh and current borrowings rose to Rs. 373 lakh from Rs. 37 lakh. The board has recommended a Rs. 2.50 per share final dividend for FY26, subject to shareholder approval.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Nothing flagged in the filed numbers.Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from DENIS CHEM LAB LTD's filed financials and exchange disclosures
What does DENIS CHEM LAB LTD do?
DENIS CHEM LAB LTD is a Pharmaceuticals & Biotechnology company listed on BSE.
Is DENIS CHEM LAB LTD profitable?
Yes. Over the trailing twelve months DENIS CHEM LAB LTD reported a net profit of ₹8.41 Cr on revenue of ₹182 Cr.
Does DENIS CHEM LAB LTD pay a dividend?
Yes. The dividend yield is 2.44% at the current price. It paid out 25% of its profit as dividend in FY26.
Is DENIS CHEM LAB LTD debt-free?
No. It reported borrowings of ₹4.18 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹3.73 Cr after cash. Debt stands at 0.05× equity. That is lower than 61% of its 166 Pharmaceuticals peers.
Is DENIS CHEM LAB LTD expensive compared with its peers?
On trailing P/E, DENIS CHEM LAB LTD ranks 19 of 158 in Pharmaceuticals — cheaper than 89% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.
How much does the DENIS CHEM LAB LTD share price move in a day?
On a typical session DENIS CHEM LAB LTD moves 1.29% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
When are DENIS CHEM LAB LTD's next results?
Financial Results on Wed, 4 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track DENIS CHEM LAB LTD's announcements?
Every NSE and BSE filing by DENIS CHEM LAB LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.